Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas
- 1 March 1998
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 114 (3) , 441-447
- https://doi.org/10.1016/s0016-5085(98)70526-8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Long-term use of nonsteroidal antiinflammatory drugs and other chemopreventors and risk of subsequent colorectal neoplasiaDigestive Diseases and Sciences, 1996
- Nonsteroidal Antiinflammatory Drugs Inhibit the Proliferation of Colon Adenocarcinoma Cells: Effects on Cell Cycle and ApoptosisExperimental Cell Research, 1996
- Prospects for Preventing Colorectal Cancer DeathJNCI Journal of the National Cancer Institute, 1993
- Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 ratsCarcinogenesis: Integrative Cancer Research, 1993
- Reduced Risk of Large-Bowel Adenomas Among Aspirin UsersJNCI Journal of the National Cancer Institute, 1993
- Incidence of Cancer Among Patients With Rheumatoid ArthritisJNCI Journal of the National Cancer Institute, 1993
- Piroxicam and other cyclooxygenase inhibitors: Potential for cancer chemopreventionJournal of Cellular Biochemistry, 1992
- Aspirin Use and Incidence of Large-Bowel Cancer in a California Retirement CommunityJNCI Journal of the National Cancer Institute, 1991
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Randomised trial of prophylactic daily aspirin in British male doctorsBMJ, 1988